AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $248.08
-
Support level$219.89
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)74.7
- Down 5.0 percent, ABBV is one of this week's biggest decliners.
- Volatility is forecast to fall over the next month.
- ABBV is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, ABBV is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $184.85 | $261.07 | 85.2% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $222.79 | $223.92 | $240.43 | $253.16 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.0%
-
In the next month13.6%
-
In the next year49.2%
| Period | Value |
|---|---|
| Historical (5 year) | 23.4% |
| Last month | 21.7% |
| Current estimate | 25.6% |
| Next month forecast | 24.0% |